Researchers have now demonstrated the significance and translational potential of nanodiamonds in the treatment of chemotherapy-resistant cancers. In studies of liver and breast cancer models in vivo, the team found that a normally lethal amount of a chemotherapy drug when bound to nanodiamonds significantly reduced the size of tumors in mice. Survival rates also increased and no toxic effects on tissues and organs were observed.